The BioCanRx vision is to turn all cancers into curable diseases. We invest in leading edge immune oncology research translating world-class technologies from the lab into early phase clinical trials. BioCanRx provides researchers with access to funding, expertise, training and biomanufacturing facilities and is a leader in the translation, manufacture and adoption of cancer immunotherapies.

 

What's Happening at BioCanRx


Revolutionizing the treatment of cancer in children
Dr. Uri Tabori holds positions as the head of the neuro-oncology program at the Hospital for Sick Children, a Professor of Paediatrics and Medical Biophysics at the University of Toronto.
Both Sides of the Learning Institute 2022 Experience
Long before meeting in person in Montreal, November 19-21, for the BioCanRx Summit for Cancer Immunotherapy (Summit4CI).
2022 Learning Institute Dissemination Report
The 2022 BioCanRx-Cancer Stakeholder Alliance Learning Institute took place as part of the Summit for Cancer Immunotherapy, November 19-21, 2022.